Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001437749-20-022768
Filing Date
2020-11-05
Accepted
2020-11-05 15:53:46
Documents
17
Period of Report
2020-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A usna20200926_10qa.htm   iXBRL 10-Q/A 56077
2 EXHIBIT 31.1 ex_211781.htm EX-31.1 10919
3 EXHIBIT 31.2 ex_211782.htm EX-31.2 11537
4 EXHIBIT 32.1 ex_211783.htm EX-32.1 3802
5 EXHIBIT 32.2 ex_211784.htm EX-32.2 3800
  Complete submission text file 0001437749-20-022768.txt   267539

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA usna-20200926.xsd EX-101.SCH 3700
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE usna-20200926_def.xml EX-101.DEF 14662
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20200926_lab.xml EX-101.LAB 19796
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20200926_pre.xml EX-101.PRE 15256
10 EXTRACTED XBRL INSTANCE DOCUMENT usna20200926_10qa_htm.xml XML 5347
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 10-Q/A | Act: 34 | File No.: 001-35024 | Film No.: 201290262
SIC: 2833 Medicinal Chemicals & Botanical Products